A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume -, Issue -, Pages 1-11
Publisher
IOS Press
Online
2019-09-10
DOI
10.3233/cbm-190210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature
- (2018) Soum D. Lokeshwar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Colorectal Cancers: An Update on Their Molecular Pathology
- (2018) Kentaro Inamura Cancers
- Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer
- (2018) Christopher G. Hurtado et al. GASTROENTEROLOGY
- IL-17A–Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis
- (2017) Jarod A. Zepp et al. JOURNAL OF IMMUNOLOGY
- An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer
- (2017) Yaqiong Chen et al. Scientific Reports
- Innate Lymphoid Cells in Intestinal Inflammation
- (2017) Alessandra Geremia et al. Frontiers in Immunology
- Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
- (2016) Dongsheng Xu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Activation of CXCL12/CXCR4 renders colorectal cancer cells less sensitive to radiotherapy via up-regulating the expression of survivin
- (2016) Dawei Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer
- (2016) Yoon Ji Choi et al. OncoTargets and Therapy
- CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis
- (2015) You-Chuan Xiao et al. CANCER LETTERS
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- Prognostic Value, Clinicopathologic Features and Diagnostic Accuracy of Interleukin-8 in Colorectal Cancer: A Meta-Analysis
- (2015) Wenjie Xia et al. PLoS One
- Survival Paradox Between Stage IIB/C (T4N0) and Stage IIIA (T1-2N1) Colon Cancer
- (2014) Min Jung Kim et al. ANNALS OF SURGICAL ONCOLOGY
- SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
- (2014) Ting-hua Hu et al. CANCER LETTERS
- CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transition
- (2014) Xian-Shuo Cheng et al. CANCER LETTERS
- Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer
- (2014) Kathrin Rupertus et al. CLINICAL & EXPERIMENTAL METASTASIS
- Interleukin-17 is a favorable prognostic marker for colorectal cancer
- (2014) Y. Lin et al. Clinical & Translational Oncology
- Tools and Techniques - Statistics: How many variables are allowed in the logistic and Cox regression models?
- (2014) Ron van Domburg et al. EuroIntervention
- A role for G-CSF and GM-CSF in nonmyeloid cancers
- (2014) Alexander M. Aliper et al. Cancer Medicine
- Interleukin-17: A Promoter in Colorectal Cancer Progression
- (2013) Dang Wu et al. Clinical & Developmental Immunology
- The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis
- (2013) Shunzeng Lv et al. HISTOPATHOLOGY
- Chemokine and Chemokine Receptor Expression in Kidney Tumors: Molecular Profiling of Histological Subtypes and Association With Metastasis
- (2012) Jeffrey C. Gahan et al. JOURNAL OF UROLOGY
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular characterization of kidney cancer
- (2011) Andrew Chi et al. CANCER
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis
- (2010) Mario W. Kramer et al. CANCER
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
- (2010) Reiko M. Onishi et al. IMMUNOLOGY
- Nuclear expression of CXCR4 is associated with advanced colorectal cancer
- (2010) Shang-Chiung Wang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma
- (2009) Yuri Akishima-Fukasawa et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The role of stromal-derived factor-1 — CXCR7 axis in development and cancer
- (2009) Radoslaw B. Maksym et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
- (2008) N Yoshitake et al. BRITISH JOURNAL OF CANCER
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now